Insider · CIK 0001586785

NEIL GARRY ARTHUR

Reports to the SEC for 6 companies · HAMPTON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001586785

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-25	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+26K sh	—	—	26,000
2026-05-21	AVTXAvalo Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	190,314
2026-03-28	AVTXAvalo Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+64.9K sh	—	—	112,006
2026-03-28	AVTXAvalo Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−21.9K sh	$13.89	−$304K	90,114
2026-03-28	AVTXAvalo Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−64.9K sh	—	—	64,867
2026-02-26	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+286K sh	—	—	286,000
2025-06-05	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+16.5K sh	—	—	16,500
2025-03-28	AVTXAvalo Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+64.9K sh	—	—	64,927
2025-03-28	AVTXAvalo Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−17.8K sh	$8.46	−$150K	47,140
2025-03-28	AVTXAvalo Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+64.9K sh	—	—	129,733
2025-01-28	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+411K sh	—	—	411,000
2024-08-13	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+500K sh	—	—	500,400
2024-08-13	AVTXAvalo Therapeutics, Inc. · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+195K sh	—	—	194,600
2024-06-13	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+16.5K sh	—	—	16,500
2023-06-15	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,300
2023-06-09	AVTXAvalo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+4,000 sh	$3.42	+$13.7K	13,220
2023-05-18	ZURAZura Bio Ltd · Employee Share Option (Right to Buy)A Award	Director	AAward	+7,652 sh	—	—	7,652
2023-05-15	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	100,000
2023-02-13	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	100,000
2022-12-09	AVTXAvalo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,083 sh	$4.42	+$9,206.86	9,220
2022-10-05	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+75K sh	—	—	75,000
2022-06-16	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+27.2K sh	—	—	27,200
2022-03-11	ARENA PHARMACEUTICALS INCJ Other	Director	JOther	−8,150 sh	—	—	3,067
2022-03-11	ARENA PHARMACEUTICALS INCJ Other	Director	JOther	−3,067 sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,167 sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,202 sh	—	—	0
2022-03-08	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+1M sh	—	—	1,000,000
2021-12-10	AVTXAvalo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+4,267 sh	$1.57	+$6,699.19	85,639
2021-06-11	ARENA PHARMACEUTICALS INCA Award	Director	AAward	+3,067 sh	—	—	11,217
2021-06-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+7,202 sh	—	—	7,202
2021-06-10	AVTXAvalo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+3,692 sh	$2.28	+$8,417.76	81,372
2021-01-26	AVTXAvalo Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+260K sh	—	—	260,000
2020-12-10	AVTXAvalo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+3,599 sh	$2.28	+$8,198.522	77,680
2020-06-12	ARENA PHARMACEUTICALS INCA Award	Director	AAward	+2,446 sh	—	—	8,150
2020-06-12	ARENA PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2020-06-10	AVTXAvalo Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1,799 sh	$2.28	+$4,098.122	74,081
2020-02-03	Aevi Genomic Medicine, LLCD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−2.16M sh	—	—	0
2020-02-03	Aevi Genomic Medicine, LLCStock Option (Right to Purchase)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−900K sh	—	—	0
2020-02-03	Aevi Genomic Medicine, LLCStock Option (Right to Purchase)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−13.5K sh	—	—	0
2020-02-03	Aevi Genomic Medicine, LLCStock Option (Right to Purchase)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−200K sh	—	—	0
2020-02-03	Aevi Genomic Medicine, LLCStock Option (Right to Purchase)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−200K sh	—	—	0
2020-02-03	Aevi Genomic Medicine, LLCStock Option (Right to Purchase)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−200K sh	—	—	0
2020-02-03	Aevi Genomic Medicine, LLCStock Option (Right to Purchase)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−100K sh	—	—	0
2020-02-03	Aevi Genomic Medicine, LLCWarrant (Right to Purchase)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−13.3K sh	—	—	0
2020-02-03	Aevi Genomic Medicine, LLCStock Option (Right to Purchase)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−300K sh	—	—	0

Recent filings

Accepted (ET)
Jun 294
NEIL GARRY ARTHUR0001586785-26-000008
SEC(opens sec.gov)
May 264
NEIL GARRY ARTHUR0001586785-26-000006
SEC(opens sec.gov)
Mar 314
NEIL GARRY ARTHUR0001586785-26-000004
SEC(opens sec.gov)
Mar 24
NEIL GARRY ARTHUR0001586785-26-000002
SEC(opens sec.gov)
Jun 94
NEIL GARRY ARTHUR0001415889-25-016222
SEC(opens sec.gov)
Apr 14
NEIL GARRY ARTHUR0001578563-25-000197
SEC(opens sec.gov)
Jan 304
NEIL GARRY ARTHUR0001578563-25-000027
SEC(opens sec.gov)
Aug 144
NEIL GARRY ARTHUR0001578563-24-000363
SEC(opens sec.gov)
Jun 174
NEIL GARRY ARTHUR0001415889-24-017155
SEC(opens sec.gov)
Jun 204
NEIL GARRY ARTHUR0001415889-23-010036
SEC(opens sec.gov)
Jun 134
NEIL GARRY ARTHUR0001628280-23-021958
SEC(opens sec.gov)
May 224
NEIL GARRY ARTHUR0001104659-23-063319
SEC(opens sec.gov)
May 174
NEIL GARRY ARTHUR0001628280-23-018556
SEC(opens sec.gov)
Feb 154
NEIL GARRY ARTHUR0001628280-23-003706
SEC(opens sec.gov)
Dec 124
NEIL GARRY ARTHUR0001628280-22-031725
SEC(opens sec.gov)

Companies

Address

C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 202

HAMPTON, NJ, 08827